By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TG Therapeutics, Inc. 

787 Seventh Avenue
48th Floor
New York  New York  10019  U.S.A.
Phone: 212-554-4484 Fax: 212-554-4531


SEARCH JOBS


Industry
Pharmaceutical






Company News
TG Therapeutics, Inc. (MHA) Release: Updated Results From Phase II Clinical Trial Of TG-1101 (Ublituximab) In Combination With Ibrutinib Confirms Robust Clinical Activity With A Favorable Safety Profile In Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL) 6/18/2015 11:19:06 AM
TG Therapeutics, Inc. (MHA) To Present Clinical Data On TG-1101 And TGR-1202 At The 20th Congress Of The European Hematology Association And The 13th International Congress On Malignant Lymphoma 6/12/2015 7:14:43 AM
TG Therapeutics, Inc. (MHA) To Present At The Jefferies and Co. 2015 Healthcare Conference 6/2/2015 10:50:37 AM
ASCO15: TG Therapeutics, Inc. (MHA) Announces The Triple Combination Of TG-1101, TGR-1202 And Ibrutinib Is Safe And Highly Active In Patients With Advanced B-Cell Malignancies 6/1/2015 10:39:46 AM
ASCO15: TG Therapeutics, Inc. (MHA) Announces Presentations Of Its Proprietary Combination Of TG-1101 Plus TGR-1202 As Well As TGR-1202 As A Single Agent In Ongoing Phase I/Ib Dose Escalation Clinical Studies 6/1/2015 8:12:14 AM
ASCO15: TG Therapeutics, Inc. (MHA) Recaps Schedule Of Clinical Data Presentations At The 51st Annual Meeting Of The ASCO 5/29/2015 1:13:07 PM
TG Therapeutics, Inc. (MHA) Announces Clinical Data Presentations At The Upcoming 51st Annual Meeting Of The ASCO 5/14/2015 1:09:43 PM
TG Therapeutics, Inc. (MHA) Announces First Quarter 2015 Financial Results And Business Update 5/4/2015 2:46:19 PM
TG Therapeutics, Inc. (MHA) To Present At The Deutsche Bank (DB) 40th Annual Health Care Conference 5/1/2015 10:26:31 AM
TG Therapeutics, Inc. (MHA) To Host Conference Call On First Quarter 2015 Financial Results And Business Update 4/30/2015 8:28:39 AM
12345678910...
//-->